Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Implementation of an Intensified Thromboprofylaxis Protocol in in Critically Ill ICU Patients With COVID-19: a Longitudinal Controlled Before-after Study

NCT04394000 is registered in ClinicalTrials.gov with Jessa Hospital as lead sponsor.

NCT NCT04394000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04394000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Implementation of an Intensified Thromboprofylaxis Protocol in in Critically Ill ICU Patients With COVID-19: a Longitudinal Controlled Before-after Study
Lead sponsor
Jessa Hospital
Phase
Observational
Overall status
Completed
Start date
May 4, 2020
Completion date
May 15, 2020
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, thromboembolism